ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,194,024 | -11.6% | 43,995 | +0.1% | 0.11% | -16.4% |
| Q2 2023 | $1,350,992 | -14.7% | 43,949 | 0.0% | 0.13% | -22.1% |
| Q1 2023 | $1,583,482 | -8.9% | 43,949 | -0.1% | 0.17% | -16.9% |
| Q4 2022 | $1,737,892 | -48.5% | 43,975 | -47.6% | 0.21% | -52.3% |
| Q3 2022 | $3,375,000 | -4.4% | 84,001 | 0.0% | 0.43% | -4.2% |
| Q2 2022 | $3,531,000 | -84.0% | 84,001 | -85.2% | 0.45% | -79.2% |
| Q1 2022 | $22,039,000 | -2.2% | 565,674 | +0.0% | 2.18% | -7.8% |
| Q4 2021 | $22,539,000 | +2.1% | 565,584 | -7.4% | 2.36% | -12.8% |
| Q3 2021 | $22,067,000 | +199.2% | 610,584 | +239.4% | 2.71% | +176.6% |
| Q2 2021 | $7,375,000 | – | 179,916 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |